➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Boehringer Ingelheim
Colorcon
Harvard Business School

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VINORELBINE TARTRATE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Vinorelbine Tartrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003828 S9804: Vinorelbine in Treating Patients With Stage IV Melanoma Completed National Cancer Institute (NCI) Phase 2 1999-05-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating patients who have stage IV melanoma that has been previously treated.
NCT00003828 S9804: Vinorelbine in Treating Patients With Stage IV Melanoma Completed Southwest Oncology Group Phase 2 1999-05-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating patients who have stage IV melanoma that has been previously treated.
NCT00006088 Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors Unknown status National Cancer Institute (NCI) Phase 1 2000-06-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase I trial to compare the effectiveness of two different regimens of vinorelbine in treating patients who have metastatic or advanced solid tumors.
NCT00006088 Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors Unknown status H. Lee Moffitt Cancer Center and Research Institute Phase 1 2000-06-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase I trial to compare the effectiveness of two different regimens of vinorelbine in treating patients who have metastatic or advanced solid tumors.
NCT00006682 Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer Unknown status Washington Hospital Center Phase 2 2000-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metastatic breast cancer.
NCT00140140 A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer Terminated Celgene Corporation Phase 1/Phase 2 2005-08-01 The purpose of this study is to: 1) determine the optimal tolerated dose of ABI-007 and vinorelbine, given concurrently on a weekly basis, in the absence of planned growth factor support with granulocyte colony-stimulating factor (G-CSF) (Patients with HER-2/neu positive disease may receive Herceptin, and 2) determine the optimal tolerated dose of ABI-007 and vinorelbine, given concurrently on a weekly basis, in the presence of planned growth factor support with G-CSF.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vinorelbine Tartrate

Condition Name

Condition Name for Vinorelbine Tartrate
Intervention Trials
Breast Cancer 3
Recurrent Adult Hodgkin Lymphoma 2
Adult Nodular Sclerosis Hodgkin Lymphoma 2
Stage IIIA Breast Cancer 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vinorelbine Tartrate
Intervention Trials
Breast Neoplasms 7
Carcinoma, Non-Small-Cell Lung 3
Hodgkin Disease 3
Sarcoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vinorelbine Tartrate

Trials by Country

Trials by Country for Vinorelbine Tartrate
Location Trials
United States 89
Canada 9
Italy 7
Spain 2
Australia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vinorelbine Tartrate
Location Trials
California 7
Washington 4
Illinois 4
Florida 3
District of Columbia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vinorelbine Tartrate

Clinical Trial Phase

Clinical Trial Phase for Vinorelbine Tartrate
Clinical Trial Phase Trials
Phase 2 12
Phase 1/Phase 2 3
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vinorelbine Tartrate
Clinical Trial Phase Trials
Completed 8
Unknown status 3
Not yet recruiting 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vinorelbine Tartrate

Sponsor Name

Sponsor Name for Vinorelbine Tartrate
Sponsor Trials
National Cancer Institute (NCI) 8
Wyeth is now a wholly owned subsidiary of Pfizer 1
H. Lee Moffitt Cancer Center and Research Institute 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vinorelbine Tartrate
Sponsor Trials
Other 15
Industry 10
NIH 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Baxter
Express Scripts
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.